A new license agreement announced between the Medicines Patent Pool (MPP) and ViiV Healthcare - relating to its new antiretroviral dolutegravir (DTG) - enables...
In a gathering, more research on results of faith-based HIV treatment programs was highlighted as a priority, as well as strategic communication about the...